The molecular biology enzymes, kits, and reagents market in North America is expected to grow from US$ 5,532.13 million in 2021 to US$ 17,999.75 million by 2028; it is estimated to grow at a CAGR of 18.4% from 2021 to 2028.
The US, Canada, and Mexico are major economies in North America. Genomics getting highly funded is the major factor driving the growth of the North America molecular biology enzymes, kits, and reagents market. Genome sequencing was restricted to the research facilities, a few years back. However, it has now became one of the common techniques in clinical practices. Over the next few years, the healthcare sector is expected to generate genomic data of over 60 million patients. In August 2018, Nebula Genomics, a company based in Boston, Massachusetts, along with 10 leading venture capital firms, raised US$ 4.3 million in seed funding. as a part of partnership with Veritas Genetics, a genome sequencing company. The company aims to use these funds to create a trustworthy, secure, and decentralized marketplace for genomic data. Such continuous funding by the manufacturers and governments in the field of genomics is supporting the molecular biology enzymes, kits, and reagents market growth.The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the molecular biology enzymes, kits & reagents market. Various people across the North American region are affected with corona virus. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies engaged in development of novel drugs for the treatment of life threaten diseases. Therefore, molecular biology enzymes, kits & reagents products is required in drug design & development as well as COVID-19 diagnosis.
Furthermore, due to the rising numbers of COVID-19 population has positive impact on the molecular biology enzymes, kits & reagents market. In March 2021, Eurofins' Clinical Enterprise, Inc. has obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits approved by the European Union. Thus, rising numbers of product launches support the growth of the market. Similarly, in July 2020, Eurofins U.S. Clinical Diagnostics has announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America molecular biology enzymes, kits, and reagents market. The North America molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Molecular Biology Enzymes, Kits, and Reagents Market Segmentation
North America Molecular Biology Enzymes, Kits, and Reagents Market – By Product
- Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
North America Molecular Biology Enzymes, Kits, and Reagents Market – By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
North America Molecular Biology Enzymes, Kits, and Reagents Market – By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
North America Molecular Biology Enzymes, Kits, and Reagents Market, by Country
- US
- Canada
- Mexico
North America Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 North America Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 North America Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 North America Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 North America PEST Analysis
4.1.1 Expert Opinion
5. North America Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Highly Funded
5.1.2 Sequencing Procedures becoming Cheaper
5.1.3 Rising Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Scarcity of Skilled Professionals
5.3 Market Opportunities
5.3.1 Molecular Diagnostics Getting Highly Adopted
5.4 Future Trends
5.4.1 Personalized Medicines at High Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – North America Analysis
6.1 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 North America
10.1.1 Overview
10.1.2 North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.2.1 US
10.1.2.1.1 US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.1.3 US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.1.4 US: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada
10.1.2.2.1 Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico
10.1.2.3.1 Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Molecular Biology Enzymes, Kits & Reagents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Rockland Immunochemicals, Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Promega Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. US: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. US: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. US: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 14. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. North America Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. North America Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of North America Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. North America Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. North America Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. North America Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. North America Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. North America: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. US: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in North American Country Markets
Figure 35. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Molecular Biology Enzymes, Kits, and Reagents Market
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2021